Georgia Healthcare Group PLC (“GHG” or the “Group”) announces changes to its Board of Directors (the “Board”) with effect from 20 September 2018. The changes will further strengthen the Board’s independence, reflecting its commitment to adhere to the highest standards of corporate governance.
William (Bill) Huyett, an independent non-executive director, has been appointed as Chairman of GHG’s Board of Directors. Bill replaces Irakli Gilauri, who will remain on the Board as a non-executive director.
Fabian Blank joins the Board as an independent non-executive director. He has also been appointed as a member of the Clinical Quality and Safety and Nomination Committees and will join the Supervisory Board of JSC Georgia Healthcare Group.
Ingeborg Oie has been appointed to the Audit Committee and has stepped down from the Clinical Quality and Safety Committee. Irakli Gilauri has stepped down from the Remuneration Committee, and Bill Huyett and Tim Elsigood have been appointed to the Nomination Committee.
“Firstly, I want to thank each member of the Board for their commitment and very significant contribution to the growth of the Group since its listing in November 2015. I am confident that Bill’s appointment as Chairman will further contribute to the Board’s independence and consider this change to be in the long-term interest of GHG and its shareholders. I would like to welcome Bill to his new role and look forward to continuing our work together with the entire team.” – commented Irakli Gilauri.
“I would like to congratulate Bill on his new appointment as Chairman and wish him every success in his new role. With his expertise in global healthcare systems, I am confident Bill will make great contribution to the Group, building substantial value for shareholders. I am also delighted to welcome Fabian to our Board. He brings with him a wealth of knowledge and experience in digital health, which is one of the Group’s key strategic priorities, and will be a valuable addition to the current skills mix within the Board. Finally, on behalf of the entire board, I would also like to thank Irakli for his significant input into GHG’s progress and strategic development as our Chairman. I am grateful that I will be able to continue to rely on his advice and counsel.” – commented Nikoloz Gamkrelidze, CEO of Georgia Healthcare Group.
“It gives me great pleasure to accept the Chairman’s role on the GHG Board and am proud to be a part of the Group, whose existing strong governance has resulted in exceptional momentum over the last few years. GHG has significant growth and value creation opportunities ahead. I’m excited to continue working with the rest of the Board and management to deliver on the strategic and operating priorities that will deliver on those opportunities.” – commented Bill Huyett.
დატოვე კომენტარი
